LGALS3 and hepatocellular carcinoma: LGALS3, a member of the galactoagglutinin family, is a vital gene in the regulation of the liver immune microenvironment (6, 7) and is significantly associated with increased risk of liver failure, cirrhosis, chronic active hepatitis B, and shorter survival time for hepatocellular carcinoma (HCC) (8, 9).